Cita APA (7a ed.)

M, C., D, B., R, V., & G, S. (2019). New horizons for the treatment of severe, eosinophilic asthma: Benralizumab, a novel precision biologic. Dove Medical Press.

Cita Chicago Style (17a ed.)

M, Caminati, Bagnasco D, Vaia R, y Senna G. New Horizons for the Treatment of Severe, Eosinophilic Asthma: Benralizumab, a Novel Precision Biologic. Dove Medical Press, 2019.

Cita MLA (8a ed.)

M, Caminati, et al. New Horizons for the Treatment of Severe, Eosinophilic Asthma: Benralizumab, a Novel Precision Biologic. Dove Medical Press, 2019.